Earnings Feed
Start Free
CANCER GENETICS, INC·4

Oct 2, 5:07 PM ET

Welsh Michael J. 4

4 · CANCER GENETICS, INC · Filed Oct 2, 2017

Insider Transaction Report

Form 4
Period: 2017-09-28
CANCER GENETICS, INCCGIX
Welsh Michael J.
Director
Transactions
  • Award

    Common Stock, par value $0.0001 per share

    [F1]
    2017-09-28+2,500→ 12,540 total
  • Award

    Stock Option (right to buy)

    [F2]
    2017-09-28+5,000→ 5,000 total
    Exercise: $2.75From: 2018-09-28Exp: 2027-09-28→ Common Stock, par value $0.0001 per share (5,000 underlying)
Footnotes (2)
  • [F1]The restricted stock underlying the award vests in two equal installments on September 28, 2018 and September 28, 2019, respectively.
  • [F2]The option vests in two equal installments on September 28, 2018 and September 28, 2019, respectively.
Signature
/s/ Michael J. Welsh by John A. Roberts as Attorney-in-fact|2017-10-02

Documents

1 file
  • 4
    wf-form4_150697843196930.xmlPrimary

    FORM 4